ALKBH5 and plasma cell myeloma: Our previous research has demonstrated that ALKBH5 promoted stem cell phenotype and myeloma tumorigenicity through demethylating the SAV1 mRNA of the HIPPO pathway, emphasizing the demethylation activity of ALKBH5 in MM (3).